TrialNeuro-oncology2015
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.
Thomas J Kaley et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
151 papers cite itlatest 60 shown
this paperpooled ittrialcites it